Approvals/CIMA-AEMPS/RANOLAZINA KRKA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

RANOLAZINA KRKA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Krka D.D. Novo Mesto🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6c1435d431646de7
Drug Cima Aemps Name: RANOLAZINA KRKA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 88686
Holder Company Name: Krka D.D. Novo Mesto
Marketing Company Name: Krka Farmaceutica S.L.
Authorization Date: 2023-03-07
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 375 MG
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Krka D.D. Novo Mesto

RANOLAZINA

375 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 7, 2023

Approval ID

6c1435d431646de7

Type

Standard